𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The radiation therapy of early stage cutaneous T-cell lymphoma

✍ Scribed by Bizhan Micaily; Charles Moser; Eric C Vonderheid; Christopher Koprowski; David Lightfoot; Arnold Markoe; Luther Brady

Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
754 KB
Volume
18
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of radiation therapy in the tre
The role of radiation therapy in the treatment of early stage large cell lymphoma
✍ Seymour H. Levitt; Chung K. K. Lee; Clara D. Bloomfield; Glauco Frizzera πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 312 KB

Nineteen patients with localized non-Hodgkin's lymphoma large cell type classified by the international formulation in group D ( 5 ) and group G (14) were treated with extended field radiation therapy. These patients have been followed for 168 months with range from 12 to 168 months from initiation

Cutaneous T-cell lymphoma in a patient i
Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1: Use of radiation therapy
✍ Jeffrey Goldstein; Norwin Becker; John Delrowe; Lawrence Davis πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 888 KB

A patient with cutaneous T-cell lymphoma (CTCL) and acquired immune deficiency syndrome (AIDS) is presented. The patient had a localized lesion on his scalp. Evaluation for systemic lymphoma was negative. A biopsy specimen showed superficial and deep dermal infiltrates of pleomorphic lymphocytes. Im

Treatment of erythrodermic cutaneous T-c
Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy
✍ E.A. Coors; P. Von Den Driesch πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Background: Erythrodermic cutaneous t-cell lymphomas (ctcl) including sΓ©zary syndrome have been successfully treated with daily administration of chlorambucil and prednisone (winkelmann regimen). ## Objectives: Our purpose was to determine the efficacy and safety of a low-dose pulse chemothera